Control of Plasma Uric Acid in Adults at Risk for Tumor Lysis Syndrome: Efficacy and Safety of Rasburicase Alone and Rasburicase Followed by Allopurinol Compared With Allopurinol Alone--"Results of a Multicenter Phase III Study
Links shared publicly online about this topic.
- 868total visits
Control of Plasma Uric Acid in Adults at Risk for Tumor Lysis Syndrome: Efficacy and Safety of Rasburicase Alone and Rasburicase Followed by Allopurinol Compared With Allopurinol Alone--"Results of a Multicenter Phase III Study
Control of Plasma Uric Acid in Adults at Risk for Tumor Lysis Syndrome: Efficacy and Safety of Rasburicase Alone and Rasburicase Followed by Allopurinol Compared With Allopurinol Alone--"Results of a Multicenter Phase III Study
View full resource at jco.ascopubs.org
Tags: Disease and Condition, Safety
Most Recently Shared on September 17, 2010 at 12:30 am By:
Control of Uric Acid in Tumor Lysis: Rasburicase v Rasburicase-Allopurinol v Allopurinol http://jco.ascopubs.org/content/28/27/4207.abstract
Advertisement
